lobbying_activities: 2431792

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2431792 4f1da57a-bb66-4faa-9828-597be39adf0a Q1 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 400271247 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2020 first_quarter MED Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Patent & Trademark Office (PTO),SENATE   25000 0 0 2020-04-17T13:12:15.377000-04:00